Neurocrine Biosciences Inc vs Packaging Corporation of America — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Packaging Corporation of America trades at $228.04 (market cap $20.77B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays a 2.57% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | PKG | |
|---|---|---|
Market Cap | $17.40B | $20.77B |
Sector | Health | Technology |
52-Week High | $180.55 | $246.31 |
52-Week Low | $123.10 | $191.41 |
Enterprise Value | $16.49B | $24.59B |
Dividend Yield | — | 2.57% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →